Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke
ConclusionsThis real-world study suggests that cilostazol is effective and safe for noncardioembolic ischemic stroke and may be associated with better effectiveness in hypertensive patients compared to clopidogrel.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Cilostazol | Clopidogrel | Drugs & Pharmacology | Gastroenterology | Health Insurance | Heart Attack | Hemorrhagic Stroke | Insurance | Ischemic Stroke | Plavix | Statistics | Stroke | Study